Seizure Disorder
📧 Sign up to get email alerts when something new happens for Seizure Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy [Phase 1, Phase 2]
NaviFUS Corporation is conducting a Phase 1/2 clinical trial to evaluate the safety, tolerability, and preliminary efficacy of low-intensity…
-
FDA label_change · 2025-06-14FDA Approved: VALTOCO — Supplemental Application (Neurelis, Inc)
FDA approved a supplemental application for VALTOCO (diazepam) from Neurelis, Inc. The approval updates the product labeling.
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
This clinical trial evaluates how the 2014 ILAE definition of epilepsies affects diagnosis after a first seizure, and recruitment is ongoing…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy [NA]
A completed clinical trial indicates that incorporating multidimensional psychosocial interventions improves well-being in individuals with …
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy [Phase 4]
Phase 4 trial assessing Perampanel for reducing seizure frequency in patients with high-grade glioma and focal epilepsy has been terminated …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome [Phase 3]
Phase 3 trial of two fixed doses of fenfluramine (ZX008) in children and young adults with Dravet syndrome has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Dexmedetomidine and Propofol for Pediatric MRI Sedation [Phase 4]
Phase 4 trial assessing Dexmedetomidine and Propofol for pediatric MRI sedation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo [Phase 2]
Phase 2 trial evaluating testosterone with anastrozole or placebo for sexual dysfunction in men with epilepsy and hypogonadism; results post…
-
FDA approval · 2014-07-01FDA Approved: PHENYTOIN INFATABS — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Phenytoin Infatabs (phenytoin) from Prasco Laboratories, enabling continued marketing of thi…
-
FDA approval · 2014-04-24FDA Approved: LAMOTRIGINE EXTENDED RELEASE — Supplemental Application (Par Health USA, LLC)
FDA approves a supplemental abbreviated new drug application for Lamotrigine Extended Release from Par Health USA, LLC.